ArticleBMC neurology2026

Efficacy and influencing factors of bevacizumab monotherapy and combination therapy in recurrent high-grade glioma: a twelve-year experience.

Hai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.